Vergoeding 2019-2023 voor ATC-subgroep A10BK : Natriumglucose-cotransporter-2-remmers (sglt-2-remmers)
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| A10BK01 Dapagliflozine (Forxiga ®) | 2.900.400 | 3.346.200 | 5.403.600 | 21.125.100 | 39.674.000 |
| A10BK02 Canagliflozine (Invokana ®) | 323.000 | 490.950 | 668.580 | 805.900 | 758.640 |
| A10BK03 Empagliflozine (Jardiance ®) | 2.959.500 | 3.541.100 | 4.115.700 | 12.425.900 | 22.046.100 |
| A10BK04 Ertugliflozine (Steglatro ®) | 3.560 | 6.492 | 7.368 | 9.307 | 7.988 |
| Totaal | 6.186.460 | 7.384.742 | 10.195.248 | 34.366.207 | 62.486.728 |